In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models
Journal for ImmunoTherapy of Cancer2021cited by 42position: middledoi
Novel phosphatidylserine-binding molecule enhances antitumor T-cell responses by targeting immunosuppressive exosomes in human tumor microenvironments
Journal for ImmunoTherapy of Cancer2021cited by 42position: middledoi